Skip to content
value.today

Biocept Inc.

🇺🇸 San Diego, California, USABiotechnologyFounded 2013
Total raised
$10 M
5 rounds on record
Latest round
$2 M
Aug 2017
First round on record
Mar 2010
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Biocept Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2017$2 MNo. 5$2 to $10 million

Biocept Inc.: Raise no. 5, Aug 2017

Investors in this round

1 investor had bought by the notice of Aug 14, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$110,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Lyle E. Arnold · Executive Officer
  • Michael E. Terry · Executive Officer
  • Michael Nall · Executive Officer, Director
  • Tim Kennedy · Executive Officer
  • Veena Singh · Executive Officer
  • Bruce E. Gerhardt · Director
  • Bruce E. Huebner · Director
  • David Hale · Director
  • Ed E. Neff · Director
  • Ivor E. Royston · Director
  • M. Faye Wilson · Director
  • Marsha A. Chandler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On fees: “Represents a 5% fee paid pursuant to a referral agreement.”
  • On the amounts: “Total Offering Amount includes up to $2,151,958.50 to be received upon the exercise of warrants to purchase Common Stock; such warrants have not yet been exercised.”

Signed by Timothy Kennedy, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 14, 2017. Read the notice at the SEC.

equity, optionsSEC
Dec 2015$1 MNo. 4Under $2 million

Biocept Inc.: Raise no. 4, Dec 2015

Investors in this round

1 investor had bought by the notice of Dec 23, 2015: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $15 M offered; $14 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Lyle W Arnold · Executive Officer
  • Mark W Foletta · Executive Officer
  • Michael W Nall · Executive Officer, Director
  • Raaj W Trivedi · Executive Officer
  • Veena W Singh · Executive Officer
  • Bruce A Huebner · Director
  • Bruce E Gerhardt · Director
  • David F Hale · Director
  • Edward A Neff · Director
  • Ivor A Royston · Director
  • M Faye Wilson · Director
  • Marsha A Chandler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Foletta, Interim CFO. Source: SEC Form D, newest notice filed Dec 23, 2015. Read the notice at the SEC.

equitySEC
Feb 2011$1 MNo. 3Under $2 million

Biocept Inc.: Raise no. 3, Feb 2011

Investors in this round

1 investor had bought by the notice of Feb 16, 2011: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $6 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Farideh Bischoff · Executive Officer · Interim Chief Scientific Officer
  • Meg McGilley · Executive Officer
  • Todd Johnson · Executive Officer
  • Bruce Gerhardt · Director
  • Claire Reiss · Director
  • Daniel Petree · Director
  • Edward Dennis · Director
  • Edward Neff · Director
  • Faye Wilson · Director
  • Ivor Royston · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount listed above under Total Offering Amount includes $1,000,000 receivable by the Issuer upon the exercise of warrants to purchase shares of the Issuers Convertible Preferred Stock. Such warrants have not been exercised.”
  • On a merger: “Securities offered consist of promissory notes convertible into shares of convertible preferred stock, warrants exercisable for shares of convertible preferred stock and the common stock underlying the convertible preferred stock.”

Signed by Meg McGilley, Cfo. Source: SEC Form D, newest notice filed Feb 16, 2011. Read the notice at the SEC.

debt, optionsSEC
Aug 2010$2 MNo. 2$2 to $10 million

Biocept Inc.: Raise no. 2, Aug 2010

Investors in this round

1 investor had bought by the notice of Aug 12, 2010: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $7 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Stephen Coutts · Executive Officer, Director
  • Bruce Gerhardt · Director
  • Claire Reiss · Director
  • Daniel Petree · Director
  • Edward Dennis · Director
  • Edward Neff · Director
  • Faye Wilson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series BB Preferred Stock Financing”

Signed by Stephen M. Coutts, President & CEO. Source: SEC Form D, newest notice filed Aug 12, 2010. Read the notice at the SEC.

equitySEC
Mar 2010$4 MNo. 1$2 to $10 million

Biocept Inc.: Raise no. 1, Mar 2010

Investors in this round

4 investors had bought by the notice of Mar 29, 2010: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Jennifer K. Crittenden · Executive Officer
  • Stephen Coutts · Executive Officer, Director
  • Claire Reiss · Director
  • Daniel Petree · Director
  • Edward Dennis · Director
  • Edward Neff · Director
  • Faye Wilson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jennifer K. Crittenden, Cfo. Source: SEC Form D, newest notice filed Mar 29, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Biocept Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2017).

    SEC Form D · Aug 2017

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2017

That is all the official record says: Biocept Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Biocept Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 4 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Biocept Inc.
NameRoleNamed in
Lyle E. ArnoldExecutive officerAug 2017
Michael E. TerryExecutive officerAug 2017
Michael NallExecutive officerAug 2017
Tim KennedyExecutive officerAug 2017
Veena SinghExecutive officerAug 2017
Lyle W ArnoldExecutive officerDec 2015
Mark W FolettaExecutive officerDec 2015
Michael W NallExecutive officerDec 2015
Raaj W TrivediExecutive officerDec 2015
Veena W SinghExecutive officerDec 2015
Farideh BischoffInterim Chief Scientific OfficerFeb 2011
Meg McGilleyExecutive officerFeb 2011
Todd JohnsonExecutive officerFeb 2011
Stephen CouttsExecutive officerAug 2010
Jennifer K. CrittendenExecutive officerMar 2010
Bruce E. GerhardtDirectorAug 2017
Bruce E. HuebnerDirectorAug 2017
David HaleDirectorAug 2017
Ed E. NeffDirectorAug 2017
Ivor E. RoystonDirectorAug 2017
M. Faye WilsonDirectorAug 2017
Marsha A. ChandlerDirectorAug 2017
Michael NallDirectorAug 2017
Bruce A HuebnerDirectorDec 2015
Bruce E GerhardtDirectorDec 2015
David F HaleDirectorDec 2015
Edward A NeffDirectorDec 2015
Ivor A RoystonDirectorDec 2015
M Faye WilsonDirectorDec 2015
Marsha A ChandlerDirectorDec 2015
Michael W NallDirectorDec 2015
Bruce GerhardtDirectorFeb 2011
Claire ReissDirectorFeb 2011
Daniel PetreeDirectorFeb 2011
Edward DennisDirectorFeb 2011
Edward NeffDirectorFeb 2011
Faye WilsonDirectorFeb 2011
Ivor RoystonDirectorFeb 2011
Stephen CouttsDirectorAug 2010